reference/2287898

http://rdf.ncbi.nlm.nih.gov/pubchem/reference/2287898

Outgoing Links

Predicate	Object
contentType	Clinical Trial\|Journal Article
endingPage	622
issn	0895-7061
issueIdentifier	8
pageRange	617-622
publicationName	American Journal of Hypertension
startingPage	617
bibliographicCitation	Shargorodsky M, Wainstein J, Gavish D, Leibovitz E, Matas Z, Zimlichman R, Wainstein G, Gavish E, Leibovitz Z, Matas D. Treatment with rosiglitazone reduces hyperinsulinemia and improves arterial elasticity in patients with type 2 diabetes mellitus. Am J Hypertens. 2003 Aug;16(8):617–22. doi: 10.1016/s0895-7061(03)00911-7. PMID: 12878365.
creator	http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_504f1fe82b220a3d2c83077173b1425e http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_316dbf549aabce830da635d19d13f01c http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_a16c2f5a56d8d9c49ef35a5adc0c5919 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_87f766ebd8b5f569d7ca2ba96ed9f6ac http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_685cc3448e58dd450b10fc1ab3c3771f http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_ac5ee542cedff582225aadedc2d3dad6 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_1b0d20af8401f431495b3f64cb1f07d2 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_985bae275a4efe0168ec437f7912a00e http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_5a4780645993c293e98545e484f2663e http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_9eaf5910d62e3e6401e857568e2e0c4d
date	200308
identifier	https://doi.org/10.1016/s0895-7061%2803%2900911-7 https://pubmed.ncbi.nlm.nih.gov/12878365
isPartOf	http://rdf.ncbi.nlm.nih.gov/pubchem/journal/1520 https://portal.issn.org/resource/ISSN/0895-7061
language	English
source	https://pubmed.ncbi.nlm.nih.gov/ https://www.crossref.org/
title	Treatment with rosiglitazone reduces hyperinsulinemia and improves arterial elasticity in patients with type 2 diabetes mellitus
discusses	http://id.nlm.nih.gov/mesh/M0447306 http://id.nlm.nih.gov/mesh/M0002696 http://id.nlm.nih.gov/mesh/M0237199 http://id.nlm.nih.gov/mesh/M0010903
hasPrimarySubjectTerm	http://id.nlm.nih.gov/mesh/D006946Q000188 http://id.nlm.nih.gov/mesh/D007004Q000627 http://id.nlm.nih.gov/mesh/D003924Q000503 http://id.nlm.nih.gov/mesh/D003924Q000188 http://id.nlm.nih.gov/mesh/D045162Q000627 http://id.nlm.nih.gov/mesh/D001158Q000503
hasSubjectTerm	http://id.nlm.nih.gov/mesh/D004548 http://id.nlm.nih.gov/mesh/D015430Q000187 http://id.nlm.nih.gov/mesh/D000077154 http://id.nlm.nih.gov/mesh/D001786Q000378 http://id.nlm.nih.gov/mesh/D000328 http://id.nlm.nih.gov/mesh/D008297 http://id.nlm.nih.gov/mesh/D001794Q000502 http://id.nlm.nih.gov/mesh/D001794Q000187 http://id.nlm.nih.gov/mesh/D005260 http://id.nlm.nih.gov/mesh/D006801 http://id.nlm.nih.gov/mesh/D008875 http://id.nlm.nih.gov/mesh/D003187 http://id.nlm.nih.gov/mesh/D012307 http://id.nlm.nih.gov/mesh/D006339Q000502 http://id.nlm.nih.gov/mesh/D000368 http://id.nlm.nih.gov/mesh/D006339Q000187 http://id.nlm.nih.gov/mesh/D014655Q000502 http://id.nlm.nih.gov/mesh/D014655Q000187
discussesAsDerivedByTextMining	http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID6838 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5793 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_cdf1e220d89c2dcd2e000c3d105bf93e http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7181 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8102 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8989 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7444 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8075 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_fb20d0047710c783a714691f1da3274e http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID10071 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID77999 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID9709

Incoming Links

Predicate	Subject
isDiscussedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127796644 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127863084

Total number of triples: 69.